Magnetic resonance imaging (118) | ![]() |
Nuclear medicine (20) | ![]() |
Tomography (122) | ![]() |
Nuclear medicine in particular could benefit from the new method, the researchers say. Many stable isotopes are precursors to the short-lived radioisotopes used in medical imaging
Ian Armstrong, a nuclear medicine physicist who led the study, said: espite improvements in PET technology, we haven seen any change in the guidance regarding the amount of injected radiotracer we should use for FDG PET.
and the European Association of Nuclear medicine (EANM). ICNC 12 is held 3 to 5 may 2015 in Madrid, Spain.
The first was a nuclear medicine radioisotope technique called beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) scintigraphy1
The study included 677 patients from the multicentre, prospective cohort study B-SAFE. 4 BMIPP scintigraphy, ECG and C reactive-protein protein assessment was performed in all patients.
Patients who suffered sudden cardiac death were more likely to have abnormal BMIPP scintigraphy, abnormal Q wave
In a clinical setting, BMIPP scintigraphy can be used in hemodialysis patients who are identified as high risk by abnormal Q wave and increased C reactive-protein protein.
"Further diagnostic tests should be considered in high risk patients with abnormal BMIPP scintigraphy. Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury
Scintigraphy is a diagnostic test in nuclear medicine. Radioisotopes are injected and the radiation emitted is used to create 2d images.
and the European Association of Nuclear medicine (EANM). ICNC 12 is held 3 to 5 may 2015 in Madrid, Spain.
The first was a nuclear medicine radioisotope technique called beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) scintigraphy1
The study included 677 patients from the multicentre, prospective cohort study B-SAFE. 4 BMIPP scintigraphy, ECG and C reactive-protein protein assessment was performed in all patients.
Patients who suffered sudden cardiac death were more likely to have abnormal BMIPP scintigraphy, abnormal Q wave
In a clinical setting, BMIPP scintigraphy can be used in hemodialysis patients who are identified as high risk by abnormal Q wave and increased C reactive-protein protein.
"Further diagnostic tests should be considered in high risk patients with abnormal BMIPP scintigraphy. Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury
Oncosil, implantable nuclear medicine (radiotherapy) device, has been piloted successfully for treating pancreatic and liver cancer. The device was found to be safe and effective in laboratory studies
versus images of a live subject,"said Zhen Liu, a doctoral candidate from the department of nuclear medicine at the Technical University of Munich."
Direct positron imaging is a nuclear medicine technique that allows researchers to gain physiological information from radiolabeled imaging agents that bind to targets in the body.
The research was to be presented during the annual meeting of the Society of Nuclear medicine and Molecular Imaging in Baltimore e
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011